Clinical Trial Update: OTIS Vedolizumab Pregnancy Exposure Registry

View source ↗

Summary

This clinical trial registry update reports that the OTIS Vedolizumab Pregnancy Exposure Registry (NCT02678052) has completed data collection for ulcerative col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative, Crohn's Disease | Status: COMPLETED